116 related articles for article (PubMed ID: 11450000)
1. Bradykinin 2 receptor antagonist LF 16-0687Ms reduces posttraumatic brain edema.
Stover JF; Dohse NK; Unterberg AW
Acta Neurochir Suppl; 2000; 76():171-5. PubMed ID: 11450000
[TBL] [Abstract][Full Text] [Related]
2. Significant reduction in brain swelling by administration of nonpeptide kinin B2 receptor antagonist LF 16-0687Ms after controlled cortical impact injury in rats.
Stover JF; Dohse NK; Unterberg AW
J Neurosurg; 2000 May; 92(5):853-9. PubMed ID: 10794301
[TBL] [Abstract][Full Text] [Related]
3. Effect of LF 16-0687MS, a new nonpeptide bradykinin B2 receptor antagonist, in a rat model of closed head trauma.
Pruneau D; Chorny I; Benkovitz V; Artru A; Roitblat L; Shapira Y
J Neurotrauma; 1999 Nov; 16(11):1057-65. PubMed ID: 10595822
[TBL] [Abstract][Full Text] [Related]
4. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats.
Schulz J; Plesnila N; Eriskat J; Stoffel M; Pruneau D; Baethmann A
Acta Neurochir Suppl; 2000; 76():137-9. PubMed ID: 11449993
[TBL] [Abstract][Full Text] [Related]
5. Role of bradykinin B2 receptors in the formation of vasogenic brain edema in rats.
Plesnila N; Schulz J; Stoffel M; Eriskat J; Pruneau D; Baethmann A
J Neurotrauma; 2001 Oct; 18(10):1049-58. PubMed ID: 11686492
[TBL] [Abstract][Full Text] [Related]
6. Effects of LF 16-0687 Ms, a bradykinin B(2) receptor antagonist, on brain edema formation and tissue damage in a rat model of temporary focal cerebral ischemia.
Zausinger S; Lumenta DB; Pruneau D; Schmid-Elsaesser R; Plesnila N; Baethmann A
Brain Res; 2002 Sep; 950(1-2):268-78. PubMed ID: 12231253
[TBL] [Abstract][Full Text] [Related]
7. LF 16-0687 Ms, a bradykinin B2 receptor antagonist, reduces brain edema and improves long-term neurological function recovery after closed head trauma in rats.
Kaplanski J; Pruneau D; Asa I; Artru AA; Azez A; Ivashkova Y; Rudich Z; Shapira Y
J Neurotrauma; 2002 Aug; 19(8):953-64. PubMed ID: 12225655
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective properties of aptiganel HCL (Cerestat) following controlled cortical impact injury.
Kroppenstedt SN; Schneider GH; Thomale UW; Unterberg AW
Acta Neurochir Suppl; 1998; 71():114-6. PubMed ID: 9779160
[TBL] [Abstract][Full Text] [Related]
9. Riluzole reduces brain swelling and contusion volume in rats following controlled cortical impact injury.
Stover JF; Beyer TF; Unterberg AW
J Neurotrauma; 2000 Dec; 17(12):1171-8. PubMed ID: 11186230
[TBL] [Abstract][Full Text] [Related]
10. The importance of kinin antagonist treatment timing in closed head trauma.
Rachinsky M; Pruneau D; Artru AA; Kapuler V; Alonchin A; Smolanezki Y; Shapira Y
J Trauma; 2001 Nov; 51(5):944-8. PubMed ID: 11706345
[TBL] [Abstract][Full Text] [Related]
11. Isoflurane doubles plasma glutamate and increases posttraumatic brain edema.
Stover JF; Kroppenstedt SN; Thomale UW; Kempski OS; Unterberg AW
Acta Neurochir Suppl; 2000; 76():375-8. PubMed ID: 11450048
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of bradykinin B2 receptors before, not after onset of experimental subarachnoid hemorrhage prevents brain edema formation and improves functional outcome.
Thal SC; Sporer S; Schmid-Elsaesser R; Plesnila N; Zausinger S
Crit Care Med; 2009 Jul; 37(7):2228-34. PubMed ID: 19487935
[TBL] [Abstract][Full Text] [Related]
13. The permissive nature of blood brain barrier (BBB) opening in edema formation following traumatic brain injury.
Beaumont A; Marmarou A; Hayasaki K; Barzo P; Fatouros P; Corwin F; Marmarou C; Dunbar J
Acta Neurochir Suppl; 2000; 76():125-9. PubMed ID: 11449990
[TBL] [Abstract][Full Text] [Related]
14. Bradykinin B2, but not B1, receptor antagonism has a neuroprotective effect after brain injury.
Görlach C; Hortobágyi T; Hortobágyi S; Benyó Z; Relton J; Whalley ET; Wahl M
J Neurotrauma; 2001 Aug; 18(8):833-8. PubMed ID: 11526989
[TBL] [Abstract][Full Text] [Related]
15. Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury.
Zweckberger K; Plesnila N
Neurosci Lett; 2009 Apr; 454(2):115-7. PubMed ID: 19429066
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of aptiganel HCl (Cerestat) following controlled cortical impact injury in the rat.
Kroppenstedt SN; Schneider GH; Thomale UW; Unterberg AW
J Neurotrauma; 1998 Mar; 15(3):191-7. PubMed ID: 9528919
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological profile of LF 16-0687, a new potent non-peptide bradykinin B2 receptor antagonist.
Pruneau D; Paquet JL; Luccarini JM; Defrêne E; Fouchet C; Franck RM; Loillier B; Robert C; Bélichard P; Duclos H; Cremers B; Dodey P
Immunopharmacology; 1999 Sep; 43(2-3):187-94. PubMed ID: 10596852
[TBL] [Abstract][Full Text] [Related]
18. Bradykinin B2 receptor antagonism with LF 18-1505T reduces brain edema and improves neurological outcome after closed head trauma in rats.
Ivashkova Y; Svetnitsky A; Mayzler O; Pruneau D; Benifla M; Fuxman Y; Cohen A; Artru AA; Shapira Y
J Trauma; 2006 Oct; 61(4):879-85. PubMed ID: 17033555
[TBL] [Abstract][Full Text] [Related]
19. The effect of human corticotrophin releasing factor on the formation of post-traumatic cerebral edema.
Beaumont A; Marmarou A
Acta Neurochir Suppl; 1998; 71():149-52. PubMed ID: 9779170
[TBL] [Abstract][Full Text] [Related]
20. LF 16-0687 Ms, a new bradykinin B2 receptor antagonist, decreases ex vivo brain tissue prostaglandin E2 synthesis after closed head trauma in rats.
Kaplanski J; Asa I; Artru AA; Azez A; Ivashkova Y; Rudich Z; Pruneau D; Shapira Y
Resuscitation; 2003 Feb; 56(2):207-13. PubMed ID: 12589996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
